PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced a $7.0 million strategic investment in ...
Derma Sciences CEO Highlights Rapid Growth of MEDIHONEY Products in Presentation at Comvita Annual M
PRINCETON, N.J.--(BUSINESS WIRE)-- Derma Sciences, Inc. (NAS: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announces that its chief executive officer, Edward J.
Honey helps the treatment of some wounds better than the most modern antibiotics. For several years now medical experts from the University of Bonn have been clocking up largely positive experience ...
Amid growing concern over drug-resistant superbugs and nonhealing wounds that endanger diabetes patients, nature's original antibiotic - honey - is making a comeback. More than 4,000 years after ...
PRINCETON, N.J.--(BUSINESS WIRE)--An ancient remedy has been rediscovered for its therapeutic properties and has become a really sweet addition to treating serious wounds. MEDIHONEY™ Wound & Burn ...
Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor ...
Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K. Barry J. Wolfenson, 609-514-4744Executive Vice President, Global Marketing ...
Amid growing concern over drug-resistant superbugs and nonhealing wounds that endanger diabetes patients, nature's original antibiotic — honey — is making a comeback. More than 4,000 years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback